About usThis department’s research is directed at the identification of new targets for cartilage destruction in rheumatoid arthritis and osteoarthritis, understanding the mechanisms of chronic inflammation and auto-immunity, and the development of advanced therapeutics.
The clinical research group has a strong reputation because of the research into the assessment and prognosis of rheumatoid arthritis and systemic sclerosis.
The Disease Activity Score was developed here, and is used worldwide for the assessment of inflammatory activity in rheumatoid arthritis.
Our research is directed at refinement of prognostic predictions, ‘tight control’ strategies for tailored treatment algorithms in rheumatoid arthritis, and understanding patient and physician decision making processes. Research for systemic sclerosis is directed at early diagnosis and treatment and early detection of major complications.
DREAM registryThe Dutch Rheumatoid Arthritis Monitoring (DREAM) registry was initiated by our department and it is also coordinated here together with Univeristy of Twente. It is a Dutch network of hospitals committed to stimulate quality of care, efficient use of means and clinical research. read more
Radboudumc main entrance
Geert Grooteplein Zuid 10
6525 GA Nijmegen
Postal addressPost 470, Rheumatology
P.O. Box 9101
6500 HB Nijmegen